StockBasis
LIVE · 2026-10-31 05:20 UTC

EXEL Exelixis, Inc.

Biological Products, (No Diagnostic Substances) · Nasdaq · SEC EDGAR official

Market Value*
$9.40B
Revenue (FY)
$2.32B 2026-01-02
Net Income (FY)
$782.57M
P/E (float-based)
12.0

Financial History annual

Interactive chart · SEC EDGAR annual filings (10-K / 20-F) · enable JavaScript if blank

*Market value = public float disclosed in latest 10-K filing · CIK 939767 · SEC filings · revenue ranking · home